Our website uses its own and third parties cookies for a high level of user-friendliness. If you continue to browse and  use this website we will assume that you agree with the policies.



Atrys meets its objectives. Increases revenue by 47.4% and recurrent EBITDA by 3 times

October 26, 2016

• Revenues amounted to 1.86 million euros

• Recurrent EBITDA reached EUR 0.41 million as at 30 June 2016

• Consolidated net profit reached 0.39 million euros

Madrid, October 26th, 2016.- Atrys Health, SA, a company dedicated to provide diagnostic services and advanced medical treatments, has presented its results for the first half of 2016. The company has obtained a net benefit of 0.3 Million euros and a gross margin of 1.15 million euros. The company's revenues in this period achieved 1.86 million euros, which represents an increase of 47.4% compared to 2015, in addition to tripling its EBITDA to 0.41 million euros.